Safety considerations with combination therapies for psoriasis

被引:19
作者
Nakamura, Mio [1 ]
Koo, John [2 ]
机构
[1] Univ Michigan, Dept Dermatol, 1910 Taubman Ctr,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA
[2] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
关键词
Psoriasis; safety; combination therapy; rotational therapy; sequential therapy; phototherapy; systemic therapy; biologics; ULTRAVIOLET-B PHOTOTHERAPY; TOPICAL CORTICOSTEROIDS USEFUL; PROPIONATE SPRAY 0.05-PERCENT; CONTACT ANTHRALIN THERAPY; CHRONIC PLAQUE PSORIASIS; MU-G/G; UVB PHOTOTHERAPY; DOUBLE-BLIND; CALCIPOTRIENE OINTMENT; TREATMENT REGIMEN;
D O I
10.1080/14740338.2020.1722640
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Psoriasis is a chronic inflammatory skin disease that waxes and wanes, and long-term remission can be difficult to achieve regardless of disease severity. Currently, numerous treatment options are available for psoriasis including steroid and non-steroid topical agents, phototherapy, oral systemic agents, and biologics, with many more therapeutic agents under development. Areas covered: This article will review various combination therapy strategies such as rotational therapy and sequential therapy and describe a variety of safe and effective combination therapies for the treatment of psoriasis. Two or more agents with different mechanisms of action and safety profiles can be used to achieve and/or maintain adequate disease control while minimizing the toxicity of treatments. Combination therapy can also be used when a single agent is not enough for treating recalcitrant disease. Choosing a combination regimen that maximizes safety and efficacy while considering patient usability and compliance can be a challenge. Expert opinion: Given the various treatment options currently available for psoriasis and more agents under development, combination therapy will continue to be a valuable treatment strategy for any patient with psoriasis. It is crucial for clinicians to carefully consider the fine balance between safety and efficacy when combining various therapeutic agents.
引用
收藏
页码:489 / 498
页数:10
相关论文
共 116 条
  • [1] Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study
    AbuHilal, Mohn'd
    Walsh, Scott
    Shear, Neil
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2016, 20 (04) : 313 - 316
  • [2] [Anonymous], 2015, NEOR PACK INS
  • [3] Combining Biologic TherapiesWith Other Systemic Treatments in Psoriasis Evidence-Based, Best-Practice Recommendations From the Medical Board of the National Psoriasis Foundation
    Armstrong, April W.
    Bagel, Jerry
    Van Voorhees, Abby S.
    Robertson, Andrew D.
    Yamauchi, Paul S.
    [J]. JAMA DERMATOLOGY, 2015, 151 (04) : 432 - 438
  • [4] Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis
    Austad, J
    Bjerke, JR
    Gjertsen, BT
    Helland, S
    Livden, JK
    Morken, T
    Mork, NJ
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 1998, 11 (01) : 19 - 24
  • [5] Methotrexate and ciclosporin combination for the treatment of severe psoriasis
    Aydin, F.
    Canturk, T.
    Senturk, N.
    Turanli, A. Y.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2006, 31 (04) : 520 - 524
  • [6] Bagel J, 2017, J DRUGS DERMATOL, V16, P957
  • [7] Bagel J, 2011, J DRUGS DERMATOL, V10, P366
  • [8] Bagel J, 2009, J DRUGS DERMATOL, V8, P351
  • [9] Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel
    Behrens, S
    Grundmann-Kollmann, M
    Schiener, R
    Peter, RU
    Kerscher, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (03) : 493 - 495
  • [10] Bhutani T, 2011, J DRUGS DERMATOL, V10, P1292